OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

HTML

Year: 2009
Type: article
Study design: Clinical Trial
Source: American Journal of Clinical Oncology
DOI: 10.1097/coc.0b013e318187dd40
Authors: Margie Gerena-Lewis, Jeffrey Crawford, Philip Bonomi, Ann Marie Maddox, John Hainsworth, David E. McCune, Rakesh Shukla, Haoyue Zeigler, Paul Hurtubise, Tracy R. Chowdhury, Brandon Fletcher, Karyn Dyehouse, Richard Ghalie, Abdul R. Jazieh
Institutions: Ligand Pharmaceuticals (United States), University of Cincinnati, Duke University, Rush University Medical Center, University of Arkansas at Little Rock, Sarah Cannon, Madigan Army Medical Center
Language: English

Topic: Toxin Mechanisms and Immunotoxins
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: denileukin diftitox, interleukin-2 receptor, diphtheria toxin, fusion protein, non-small cell lung cancer, previously treated patients, treatment efficacy, treatment safety, capillary leak syndrome, myocarditis, survival, disease progression
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2005504586
FWCI: 2.205
Cites: 20
Cited by: 31
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security